Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 3826506, 9 pages
https://doi.org/10.1155/2017/3826506
Research Article

Insights into the Roles of Midazolam in Cancer Therapy

1Department of Anesthesiology, The First Affiliated Hospital, China Medical University, Shenyang 110001, China
2Department of Anesthesiology, Central Hospital, Shenyang Medical College, Shenyang 110024, China

Correspondence should be addressed to Xiaojing Jiang; moc.361@aihpos_gnaij

Received 21 March 2017; Revised 15 May 2017; Accepted 28 May 2017; Published 19 June 2017

Academic Editor: Shuang-En Chuang

Copyright © 2017 Jinghua Jiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Stefan, H. U. Häring, F. B. Hu, and M. B. Schulze, “Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications,” The Lancet Diabetes & Endocrinology, vol. 4, no. 5, pp. 457–467, 2016. View at Publisher · View at Google Scholar
  2. G. L. Snyder and S. Greenberg, “Effect of anaesthetic technique and other perioperative factors on cancer recurrence,” British Journal of Anaesthesia, vol. 105, no. 2, pp. 106–115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Desmond, N. Mulligan, M. Stokes, and D. J. Buggy, “Effect of anaesthetic technique on immune cell infiltration in breast cancer: a follow-up pilot analysis of a prospective, randomised, investigator-masked study,” Anticancer Research, vol. 35, no. 3, pp. 1311–1320, 2015. View at Google Scholar · View at Scopus
  4. N. Kocak, F. Ozen, I. H. Yildirim, and Y. Duran, “Fentanyl inhibits tumorigenesis from human breast stem cells by inducing apoptosis,” Asian Pacific Journal of Cancer Prevention, vol. 18, no. 3, pp. 735–739, 2017. View at Google Scholar
  5. F. Zhang, T. Ding, L. Yu, Y. Zhong, H. Dai, and M. Yan, “Dexmedetomidine protects against oxygen-glucose deprivation-induced injury through the I2 imidazoline receptor-PI3K/AKT pathway in rat C6 glioma cells,” Journal of Pharmacy and Pharmacology, vol. 64, no. 1, pp. 120–127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Tanabe, S. Takai, R. Matsushima-Nishiwaki, K. Kato, S. Dohi, and O. Kozawa, “α2 ad re no receptor agonist regulates protein kinase C-induced heat shock protein 27 phosphorylation in C6 glioma cells,” Journal of Neurochemistry, vol. 106, no. 2, pp. 519–528, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Álvaro-Bartolomé and J. A. García-Sevilla, “The neuroplastic index p-FADD/FADD and phosphoprotein PEA-15, interacting at GABAA receptor, are upregulated in brain cortex during midazolam-induced hypnosis in mice,” European Neuropsychopharmacology, vol. 25, no. 11, pp. 2131–2144, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. D. I. Obradović, M. M. Savić, M. M. Obradović, N. D. Ugrešić, and D. R. Bokonjić, “The lack of bicuculline and picrotoxin influence on midazolam depressant action on brain oxygen consumption,” Neuroscience Letters, vol. 397, no. 3, pp. 201–204, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Shahriari, M. Khooshideh, and M. H. Heidari, “Prevention of nausea and vomiting in caesarean section under spinal anaesthesia with midazolam or metoclopramide?” Journal of the Pakistan Medical Association, vol. 59, no. 11, pp. 756–759, 2009. View at Google Scholar · View at Scopus
  10. A. Sen, A. Rudra, S. K. Sarkar, and B. Biswas, “Intrathecal midazolam for postoperative pain relief in caesarean section delivery,” Journal of the Indian Medical Association, vol. 99, no. 12, pp. 683–686, 2001. View at Google Scholar · View at Scopus
  11. J. S. Barrett, D. Patel, E. Dombrowsky, G. Bajaj, and J. M. Skolnik, “Risk assessment of drug interaction potential and concomitant dosing pattern on targeted toxicities in pediatric cancer patients,” AAPS Journal, vol. 15, no. 3, pp. 775–786, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. F. Stevens, R. Werdehausen, N. Gaza et al., “Midazolam activates the intrinsic pathway of apoptosis independent of benzodiazepine and death receptor signaling,” Regional Anesthesia and Pain Medicine, vol. 36, no. 4, pp. 343–349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Sinner, O. Friedrich, Y. Zausig, T. Bein, and B. M. Graf, “Toxic effects of midazolam on differentiating neurons in vitro as a consequence of suppressed neuronal Ca2+-oscillations,” Toxicology, vol. 290, no. 1, pp. 96–101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Young, V. Jevtovic-Todorovic, Y.-Q. Qin et al., “Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain,” British Journal of Pharmacology, vol. 146, no. 2, pp. 189–197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Erdine, A. Yücel, S. Özyalçin et al., “Neurotoxicity of midazolam in the rabbit,” Pain, vol. 80, no. 1-2, pp. 419–423, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Glynn, “A critical appraisal tool for library and information research,” Library Hi Tech, vol. 24, no. 3, pp. 387–399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Martina, M. Clerici, V. Baldo, D. Bonetti, G. Lucchini, and M. P. Longhese, “A balance between Tel1 and Rif2 activities regulates nucleolytic processing and elongation at telomeres,” Molecular and Cellular Biology, vol. 32, no. 9, pp. 1604–1617, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Rovere-Querini, S. Brunelli, E. Clementi, and A. A. Manfredi, “Cell death: tipping the balance of autoimmunity and tissue repair,” Current Pharmaceutical Design, vol. 14, no. 3, pp. 269–277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. S. Cho, S. Y. Park, H. S. Shin, and F. K.-M. Chan, “Physiological consequences of programmed necrosis, an alternative form of cell demise,” Molecules and cells, vol. 29, no. 4, pp. 327–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. S. Ola, M. Nawaz, and H. Ahsan, “Role of Bcl-2 family proteins and caspases in the regulation of apoptosis,” Molecular and Cellular Biochemistry, vol. 351, no. 1-2, pp. 41–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Yanamadala, H. Negoro, and B. M. Denker, “Heterotrimeric G proteins and apoptosis: Intersecting signaling pathways leading to context dependent phenotypes,” Current Molecular Medicine, vol. 9, no. 5, pp. 527–545, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Kawarazaki, H. Ichijo, and I. Naguro, “Apoptosis signal-regulating kinase 1 as a therapeutic target,” Expert Opinion on Therapeutic Targets, vol. 18, no. 6, pp. 651–664, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Jendrossek, “The intrinsic apoptosis pathways as a target in anticancer therapy,” Current Pharmaceutical Biotechnology, vol. 13, no. 8, pp. 1426–1438, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Fleischer, A. Ghadiri, F. Dessauge et al., “Modulating apoptosis as a target for effective therapy,” Molecular Immunology, vol. 43, no. 8, pp. 1065–1079, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. Alam, “Apoptosis: target for novel drugs,” Trends in Biotechnology, vol. 21, no. 11, pp. 479–483, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Kasibhatla and B. Tseng, “Why target apoptosis in cancer treatment?” Molecular Cancer Therapeutics, vol. 2, no. 6, pp. 573–580, 2003. View at Google Scholar · View at Scopus
  27. Y. Tang, W. Zhan, T. Cao et al., “CacyBP/SIP inhibits Doxourbicin-induced apoptosis of glioma cells due to activation of ERK1/2,” IUBMB Life, vol. 68, no. 3, pp. 211–219, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. N. K. Mak, Y. Y. Szeto, M. C. Fung, K. N. Leung, and S. K. Kwan, “Effects of midazolam on the differentiation of murine myeloid leukemia cells,” Chemotherapy, vol. 43, no. 4, pp. 272–281, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. E. C. So, Y.-X. Lin, C. H. Tseng et al., “Midazolam induces apoptosis in MA-10 mouse leydig tumor cells through caspase activation and the involvement of MAPK signaling pathway,” OncoTargets and Therapy, vol. 7, pp. 211–221, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Ohno, K. Kobayashi, S. Uchida, O. Amano, H. Sakagami, and H. Nagasaka, “Cytotoxicity and type of cell death induced by midazolam in human oral normal and tumor cells,” Anticancer Research, vol. 32, no. 11, pp. 4737–4747, 2012. View at Google Scholar · View at Scopus
  31. E. C. So, Y.-C. Chen, S.-C. Wang et al., “Midazolam regulated caspase pathway, endoplasmic reticulum stress, autophagy, and cell cycle to induce apoptosis in MA-10 mouse leydig tumor cells,” OncoTargets and Therapy, vol. 9, pp. 2519–2533, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Braun, I. Bauer, B. Pannen, and R. Werdehausen, “Pretreatment but not subsequent coincubation with midazolam reduces the cytotoxicity of temozolomide in neuroblastoma cells,” BMC Anesthesiology, vol. 15, article 151, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. Y.-L. Dou, J.-P. Lin, F.-E. Liu et al., “Midazolam inhibits the proliferation of human head and neck squamous carcinoma cells by downregulating p300 expression,” Tumor Biology, vol. 35, no. 8, pp. 7499–7504, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Dou, Y. Li, J. Chen et al., “Inhibition of cancer cell proliferation by midazolam by targeting transient receptor potential melastatin 7,” Oncology Letters, vol. 5, no. 3, pp. 1010–1016, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. S. K. Mishra, J.-H. Kang, C. W. Lee et al., “Midazolam induces cellular apoptosis in human cancer cells and inhibits tumor growth in xenograft mice,” Molecules and Cells, vol. 36, no. 3, pp. 219–226, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Chen, Y. Dou, X. Zheng et al., “TRPM7 channel inhibition mediates midazolam-induced proliferation loss in human malignant glioma,” Tumor Biology, vol. 37, no. 11, pp. 14721–14731, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. J.-Q. Hong, S.-H. Wu, Z.-Y. Chen, W.-H. Zhuang, and H.-Z. Gao, “Effect of midazolam on mantle cell lymphoma JeKo-1 cell line and its relevant mechanisms,” Journal of experimental hematology/Chinese Association of Pathophysiology, vol. 21, no. 6, pp. 1460–1463, 2013. View at Google Scholar · View at Scopus
  38. Y. L. Dou, W. F. Liu, L. Y. Wang, and H. H. Shu, “Midazolam downregulat USP22 and inhibit the proliferation of human colon cancer SW480 cells,” Journal of Digestive Oncology (Electronic Version), vol. 4, no. 4, pp. 260–264, 2012. View at Google Scholar
  39. H. Wang, Z. Liu, Y. Gou et al., “Apoptosis and necrosis induced by novel realgar quantum dots in human endometrial cancer cells via endoplasmic reticulum stress signaling pathway,” International Journal of Nanomedicine, vol. 10, pp. 5505–5512, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. J.-J. Lin, R. Y. L. Wang, J.-C. Chen, C.-C. Chiu, M.-H. Liao, and Y.-J. Wu, “Cytotoxicity of 11-epi-sinulariolide acetate isolated from cultured soft corals on HA22T cells through the endoplasmic reticulum stress pathway and mitochondrial dysfunction,” International Journal of Molecular Sciences, vol. 17, no. 11, article 1787, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. Y.-J. Lin, S.-F. Peng, M.-L. Lin et al., “Tetrandrine induces apoptosis of human nasopharyngeal carcinoma npc-Tw 076 cells through reactive oxygen species accompanied by an endoplasmic reticulum stress signaling pathway,” Molecules, vol. 21, no. 10, article 1353, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. Z. Ren, S. Chen, J. Zhang, U. Doshi, A. P. Li, and L. Guo, “Endoplasmic reticulum stress induction and ERK1/2 activation contribute to nefazodone-induced toxicity in hepatic cells,” Toxicological Sciences, vol. 154, no. 2, pp. 368–380, 2016. View at Publisher · View at Google Scholar
  43. W. B’Chir, A.-C. Maurin, V. Carraro et al., “The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression,” Nucleic Acids Research, vol. 41, no. 16, pp. 7683–7699, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Martinou and R. J. Youle, “Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics,” Developmental Cell, vol. 21, no. 1, pp. 92–101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Cory and J. M. Adams, “The BCL2 family: regulators of the cellular life-or-death switch,” Nature Reviews Cancer, vol. 2, no. 9, pp. 647–656, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Lindsten, A. J. Ross, A. King et al., “The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues,” Molecular Cell, vol. 6, no. 6, pp. 1389–1399, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Shiraishi, M. Oku, K. Kawaguchi, D. Uchida, H. Yurimoto, and Y. Sakai, “Yeast nitrogen utilization in the phyllosphere during plant lifespan under regulation of autophagy,” Scientific Reports, vol. 5, article 9719, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. Y.-H. Teng, J.-P. Li, S.-L. Liu et al., “Autophagy protects from raddeanin A-induced apoptosis in SGC-7901 human gastric cancer cells,” Evidence-based Complementary and Alternative Medicine, vol. 2016, Article ID 9406758, 8 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. X. Peng, S. Bai, X. Ding, and K. Zhang, “Pathological impairment, cell cycle arrest and apoptosis of thymus and bursa of fabricius induced by aflatoxin-contaminated corn in Broilers,” International Journal of Environmental Research and Public Health, vol. 14, no. 1, article 77, 2017. View at Publisher · View at Google Scholar
  50. P. Pozarowski and Z. Darzynkiewicz, “Analysis of cell cycle by flow cytometry,” Methods in Molecular Biology, vol. 281, pp. 301–311, 2004. View at Google Scholar · View at Scopus
  51. G. I. Evan and K. H. Vousden, “Proliferation, cell cycle and apoptosis in cancer,” Nature, vol. 411, no. 6835, pp. 342–348, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. D. C. Bedford, L. H. Kasper, T. Fukuyama, and P. K. Brindle, “Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases,” Epigenetics, vol. 5, no. 1, pp. 9–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. R. B. Selvi, A. Swaminathan, S. Chatterjee et al., “Inhibition of p300 Lysine Acetyltransferase activity by Luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model,” Oncotarget, vol. 6, no. 41, pp. 43806–43818, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. M. M. Wong, J. S. Byun, M. Sacta, Q. Jin, S. Baek, and K. Gardner, “Promoter-bound p300 complexes facilitate post-mitotic transmission of transcriptional memory,” PLoS ONE, vol. 9, no. 6, Article ID e99989, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Jiang, M.-H. Li, K. Inoue, X.-P. Chu, J. Seeds, and Z.-G. Xiong, “Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation,” Cancer Research, vol. 67, no. 22, pp. 10929–10938, 2007. View at Publisher · View at Google Scholar · View at Scopus